In May 2020, a new grant program funding research leveraging site-less, technology-informed trials was launched, with the objective of bringing clinical trials directly to patients’ doorsteps. 

Successful proposals will: 

• Advance a treatment-based clinical trial in oncology
• Emphasize the delivery of the investigational treatment in a decentralized setting, ideally home-based
• Define compelling primary and secondary endpoints
• Creatively leverage one or more innovative technologies (telemedicine, wearables, remote monitoring, medical record review, e-consent, etc.)
• Have been reviewed with your CTO Administrative Director for regulatory, data management, and safety considerations related to implementation 
• Integrate mobile clinician management as needed
• Incorporate rigorous and methodical collection, management, and analysis of trial-related data
• Utilize clinical resources in proximity and convenient to patients for any trial-related procedures that cannot practicably be carried out in a decentralized setting (e.g. imaging, interventional radiology, complex infusion, etc.)
• Leverage strategic inter- and/or intra-institutional collaboration, including commercial (e.g. biopharmaceutical, CRO, home health companies, etc.)